Overexpression of KIAA0101 Predicts High Stage, Early Tumor Recurrence, and Poor Prognosis of Hepatocellular Carcinoma
- 15 September 2007
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 13 (18), 5368-5376
- https://doi.org/10.1158/1078-0432.ccr-07-1113
Abstract
Purpose: KIAA0101 is a proliferating cell nuclear antigen–associated factor and involved in cell proliferation. This study is to elucidate its role in the progression, early tumor recurrence (ETR), and prognosis of hepatocellular carcinoma (HCC).Keywords
This publication has 37 references indexed in Scilit:
- Role of L2DTL, Cell Cycle-Regulated Nuclear and Centrosome Protein, in Aggressive HepatocellularCarcinomaCell Cycle, 2006
- Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinomaThe Journal of Pathology, 2006
- A functional analysis of PCNA-binding peptides derived from protein sequence, interaction screening and rational designOncogene, 2006
- Suppression subtractive hybridization and expression profiling identifies a unique set of genes overexpressed in non-small-cell lung cancerOncogene, 2004
- High α‐fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: Significance of hepatitis virus infection, age, p53 and β‐catenin mutationsInternational Journal of Cancer, 2004
- Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinomaCancer, 2003
- Subcellular distribution of p21 and PCNA in normal and repair-deficient cells following DNA damageCurrent Biology, 1996
- The molecular pathogenesis of hepatocellular carcinomaJournal of Viral Hepatitis, 1994
- The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNANature, 1994
- Tumor invasiveness and prognosis in resected hepatocellular carcinoma.Clinical and pathogenetic implicationsCancer, 1988